Stock listing
NASDAQ:ABVX Abivax SA Stock
US listing (NASDAQ) of Abivax SA · home listing Euronext:ABVX
Follow Abivax SA into a list and get an email when it puts out news.
Share price · NASDAQ:ABVX
$82.10 USD -1.51 (-1.8%)
Close on Nov 17, 2026
- Day range
- $81.83 – $84.31 USDNov 17, 2026
- Volume
- 1.37M sharesNov 17, 2026
- Market cap
- $7.16B USDAt the close on Nov 17, 2026 · price × 87.27M shares outstanding
- 52-week range
- $69.81 – $148.83 USDLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
- Traded on an average day
- $111.9M USDMedian day 987,100 shares · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:ABVX · Home | €75.50 EUR | -1.40 (-1.8%) | 128,059 | €75.20 | €76.15 | €74.25 | €76.90 | Close on Nov 17, 2026 |
| NASDAQ:ABVX | $82.10 USD | -1.51 (-1.8%) | 1,372,710 | $82.86 | $84.31 | $81.83 | $83.61 | Close on Nov 17, 2026 |
| LSE:0RA9 | €75.15 EUR | -1.75 (-2.3%) | 2,062 | €76.00 | €76.00 | €74.60 | €76.90 | Close on Nov 17, 2026 |
| OTC:AAVXF | $84.80 USD | 0.00 (0.0%) | — | $84.80 | $84.80 | $84.80 | $84.80 | Close on Nov 6, 2026 |
| Frankfurt:2X1 | €77.00 EUR | +1.15 (+1.5%) | 101 | €74.65 | €77.00 | €74.65 | €75.85 | Close on Nov 17, 2026 |
| Frankfurt:2X10 | €74.00 EUR | -3.50 (-4.5%) | 40 | €74.00 | €74.00 | €74.00 | €77.50 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · NASDAQ:ABVX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $85.73 | +1.555 | +1.8% | $84.30 | $86.82 | $83.63 | 827,200 | |
| $84.18 | -5.315 | -5.9% | $91.24 | $91.32 | $83.77 | 1,233,400 | |
| $89.49 | +0.78 | +0.9% | $90.39 | $90.87 | $87.79 | 568,100 | |
| $88.71 | +3.80 | +4.5% | $85.37 | $90.12 | $85.26 | 585,200 | |
| $84.91 | -1.68 | -1.9% | $87.32 | $87.50 | $83.55 | 730,300 | |
| $86.59 | -2.47 | -2.8% | $87.66 | $88.90 | $85.81 | 842,500 | |
| $89.06 | -0.78 | -0.9% | $89.85 | $92.09 | $88.40 | 595,200 | |
| $89.84 | +2.84 | +3.3% | $87.91 | $90.98 | $87.03 | 534,200 | |
| $87.00 | +0.50 | +0.6% | $86.63 | $89.40 | $86.14 | 740,200 | |
| $86.50 | -1.51 | -1.7% | $88.01 | $88.46 | $86.25 | 423,700 | |
| $88.01 | -2.22 | -2.5% | $89.60 | $89.60 | $87.03 | 432,500 | |
| $90.23 | -3.26 | -3.5% | $92.29 | $93.98 | $88.15 | 895,400 | |
| $93.49 | +0.90 | +1.0% | $93.86 | $96.39 | $93.05 | 948,000 | |
| $92.59 | +5.10 | +5.8% | $89.61 | $94.19 | $88.44 | 1,604,400 | |
| $87.49 | -0.64 | -0.7% | $88.00 | $89.71 | $85.35 | 1,574,800 | |
| $88.13 | -4.25 | -4.6% | $91.48 | $91.48 | $86.85 | 1,445,700 | |
| $92.38 | +4.40 | +5.0% | $88.36 | $92.81 | $88.03 | 1,520,200 | |
| $87.98 | +1.76 | +2.0% | $86.12 | $89.38 | $85.88 | 1,126,500 | |
| $86.22 | -0.72 | -0.8% | $85.92 | $86.86 | $84.51 | 992,700 | |
| $86.94 | -1.21 | -1.4% | $87.32 | $87.91 | $86.40 | 658,900 | |
| $88.15 | -0.90 | -1.0% | $90.21 | $90.56 | $87.39 | 884,900 | |
| $89.05 | +2.04 | +2.3% | $86.70 | $89.10 | $84.11 | 2,102,700 | |
| $87.01 | -1.21 | -1.4% | $86.86 | $88.46 | $86.00 | 1,385,500 | |
| $88.22 | -3.51 | -3.8% | $93.67 | $93.67 | $87.83 | 2,000,500 | |
| $91.73 | -1.15 | -1.2% | $92.27 | $92.61 | $89.40 | 840,200 | |
| $92.88 | -2.22 | -2.3% | $95.82 | $95.82 | $92.58 | 644,200 | |
| $95.10 | -3.92 | -4.0% | $96.60 | $97.13 | $93.87 | 1,244,200 | |
| $99.02 | +0.52 | +0.5% | $99.34 | $100.08 | $97.46 | 886,100 | |
| $98.50 | +1.65 | +1.7% | $96.97 | $99.17 | $94.40 | 1,628,100 | |
| $96.85 | +5.79 | +6.4% | $91.50 | $97.27 | $91.45 | 1,680,000 | |
| $91.06 | -3.81 | -4.0% | $94.00 | $94.16 | $90.96 | 1,484,800 | |
| $94.87 | +0.74 | +0.8% | $92.97 | $95.88 | $91.96 | 1,663,200 | |
| $94.13 | -4.16 | -4.2% | $98.30 | $98.50 | $92.57 | 2,634,200 | |
| $98.29 | -5.16 | -5.0% | $102.74 | $102.74 | $96.74 | 2,531,400 | |
| $103.45 | -1.59 | -1.5% | $105.72 | $105.72 | $102.52 | 973,000 | |
| $105.04 | -1.95 | -1.8% | $107.00 | $107.19 | $103.89 | 876,000 | |
| $106.99 | +4.76 | +4.7% | $104.59 | $107.60 | $104.15 | 1,151,900 | |
| $102.23 | -4.43 | -4.2% | $106.38 | $107.16 | $101.29 | 1,894,300 | |
| $106.66 | -6.92 | -6.1% | $113.00 | $113.11 | $106.00 | 2,007,100 | |
| $113.58 | -5.06 | -4.3% | $116.66 | $117.14 | $113.20 | 1,156,700 | |
| $118.64 | +2.69 | +2.3% | $115.46 | $119.02 | $114.68 | 893,500 | |
| $115.95 | -3.51 | -2.9% | $117.80 | $118.75 | $114.30 | 1,287,200 | |
| $119.46 | +0.51 | +0.4% | $118.19 | $120.63 | $116.63 | 985,400 | |
| $118.95 | +4.16 | +3.6% | $114.00 | $120.30 | $112.95 | 1,605,200 | |
| $114.79 | +0.755 | +0.7% | $114.15 | $115.33 | $112.78 | 489,800 | |
| $114.04 | +2.955 | +2.7% | $112.31 | $116.10 | $112.10 | 1,111,800 | |
| $111.08 | -2.59 | -2.3% | $114.37 | $115.66 | $111.01 | 868,100 | |
| $113.67 | +1.94 | +1.7% | $111.00 | $115.11 | $110.22 | 991,300 | |
| $111.73 | -1.62 | -1.4% | $112.17 | $114.33 | $111.36 | 1,056,700 | |
| $113.35 | -0.95 | -0.8% | $114.34 | $115.17 | $111.72 | 926,200 | |
| $114.30 | -2.22 | -1.9% | $116.69 | $117.24 | $114.18 | 1,074,300 | |
| $116.52 | -1.41 | -1.2% | $117.00 | $118.00 | $116.01 | 511,300 | |
| $117.93 | +1.78 | +1.5% | $118.19 | $121.45 | $117.66 | 853,504 | |
| $116.15 | +1.20 | +1.0% | $114.00 | $116.22 | $113.29 | 1,293,320 | |
| $114.95 | -3.245 | -2.7% | $117.69 | $120.26 | $114.50 | 987,100 | |
| $118.20 | -2.365 | -2.0% | $120.00 | $120.11 | $116.20 | 1,193,500 | |
| $120.56 | +1.62 | +1.4% | $120.33 | $121.08 | $119.08 | 637,000 | |
| $118.94 | -1.79 | -1.5% | $120.00 | $121.25 | $118.50 | 481,900 | |
| $120.73 | +1.77 | +1.5% | $118.88 | $123.42 | $118.72 | 894,800 |
- Ticker
- NASDAQ:ABVX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Abivax to Participate in Upcoming Fall Investor Conferences
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 87 slides
Calls
Replays
Abivax (Euronext:ABVX) Q4 2023 Earnings Call
Mon, Apr 08, 2024 · 8:30 AM ET
Watch Transcript
Latest news
Abivax to Participate in Upcoming Fall Investor Conferences
Nov 2, 2026
Closed $88.71 (+4.5%) on Nov 3, 2026
Abivax participera à plusieurs conférences investisseurs cet automne
Nov 2, 2026
Closed $84.91 (-1.9%) on Nov 2, 2026
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.09.26
Oct 23, 2026
Closed $88.01 (-2.5%) on Oct 23, 2026
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Sep 30, 2026
Closed $95.10 (-4.0%) on Oct 1, 2026
Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026
Sep 30, 2026
Closed $99.02 (+0.5%) on Sep 30, 2026
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Sep 25, 2026
Closed $91.06 (-4.0%) on Sep 25, 2026
Abivax Presents Business Updates and First Half 2026 Financial Results
Sep 21, 2026
Closed $98.29 (-5.0%) on Sep 22, 2026
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Jul 30, 2026
Closed $124.92 (+0.5%) on Jul 31, 2026
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Jul 23, 2026
Closed $125.70 (-4.2%) on Jul 24, 2026
Abivax Announces Closing of $920 Million Public Offering
Jul 6, 2026
Closed $142.17 (-1.3%) on Jul 7, 2026
Financings
Public offering of american Depositary Shares
Jul 6, 2026
Closed: US$920M raised · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Morgan Stanley (co-lead), Piper Sandler (co-lead), Guggenheim Securities (co-lead), LifeSci Capital, Van Lanschot Kempen
Use of proceeds: Together with existing cash, to finance operations into the fourth quarter of 2029
Public offering of american Depositary Shares
Jul 2, 2026
Made bigger: about US$920M · US$125 a share · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Morgan Stanley & Co. LLC (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, Van Lanschot Kempen
Use of proceeds: Potential US commercialization of obefazimod, clinical R&D mainly in ulcerative colitis and Crohn's disease, and general corporate purposes
Announced Jun 30, 2026 · Made bigger Jul 1, 2026 · Made bigger Jul 2, 2026
Public offering of american Depositary Shares
Jul 28, 2025
Closed: US$747.5M raised · US$64 a share · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, BTIG, Van Lanschot Kempen
Use of proceeds: Finance operations into the fourth quarter of 2027, giving 12 months of cash runway after the planned NDA submission for Ulcerative Colitis
Announced Jul 23, 2025 · Update Jul 24, 2025 · Made bigger Jul 25, 2025 · Closed Jul 28, 2025
Decks
Investor Presentation (July 2026)
Investor deck · 87 slides · July 2026
Corporate Update (June 2026)
Corporate update · 56 slides · Jun 29, 2026
Investor Presentation (June 2023)
Investor deck · 35 slides · June 2023
Investor Presentation (May 2023)
Investor deck · 35 slides · May 2023
Abivax SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 30 in the last 12 months · 49 in all · newest Nov 2, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Apr 8, 2024
- Decks
- 39 decks · latest July 2026
Where Abivax SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:ABVX · Home listing | Euronext | France | EUR |
| NASDAQ:ABVX · This page | NASDAQ | United States | USD |
| LS Exchange:A14UQC | LS Exchange | Germany | EUR |
| gettex:2X1 | gettex | Germany | EUR |
| LSE:0RA9 | LSE | United Kingdom | EUR |
| Xetra:2X1 | Xetra | Germany | EUR |
| Tradegate:2X1 | Tradegate | Germany | EUR |
| OTC:AAVXF | OTC | United States | USD |
| Lang & Schwarz:A14UQC | Lang & Schwarz | Germany | EUR |
| Aquis:ABVXP | Aquis | United Kingdom | EUR |
| Frankfurt:2X1 | Frankfurt | Germany | EUR |
| gettex:2X10 | gettex | Germany | EUR |
| BX Swiss:ABVX | BX Swiss | Switzerland | CHF |
| Dusseldorf:2X1 | Dusseldorf | Germany | EUR |
| Lang & Schwarz:A3EWCP | Lang & Schwarz | Germany | EUR |
| Munich:2X1 | Munich | Germany | EUR |
| Hamburg:2X1 | Hamburg | Germany | EUR |
| Aquis:ABVXP | Aquis | United Kingdom | EUR |
| BOATS:ABVX | BOATS | United States | USD |
| Frankfurt:2X10 | Frankfurt | Germany | EUR |
| LS Exchange:A3EWCP | LS Exchange | Germany | EUR |
| Stuttgart:2X1 | Stuttgart | Germany | EUR |
| Turquoise:ABVXP | Turquoise | United Kingdom | EUR |
| VIE:ABVX | Vienna | Austria | EUR |
| Dusseldorf:2X10 | Dusseldorf | Germany | EUR |
| Hamburg:2X10 | Hamburg | Germany | EUR |
| Munich:2X10 | Munich | Germany | EUR |
| Stuttgart:2X10 | Stuttgart | Germany | EUR |
| Tradegate:2X10 | Tradegate | Germany | EUR |
| Hanover:2X1 | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Abivax SA.